Most GLP-1 receptor agonists are administered via injection, typically once a week
These medications are included in the GLP-1 receptor agonist family of drugs
Selective estrogen receptor modulators, or SERMs, such as raloxifene (Evista), mimic the bone-protective effects of estrogen in bone tissue while avoiding estrogen-related risks in other tissues, such as the breast or uterus
Only now does medical necessity enter the decision
Hypertension can be divided into primary and secondary hypertension
Acute stress on the body, from rapid weight loss, caloric restriction, or nutritional deficiency, can prematurely push a large percentage of hair follicles from the growth phase into the shedding phase at once, producing the diffuse thinning many GLP-1 patients notice roughly two to three months after starting therapy or after their most rapid period of weight loss